Low plasma lipids are associated with relapsing and lethal Visceral Leishmaniasis in HIV-infected patients (2024)
- Authors:
- USP affiliated authors: ULIANA, SILVIA RENI BORTOLIN - ICB ; YASUNAKA, JENICER KAZUMI UMADA YOKOYAMA - ICB
- Unidade: ICB
- DOI: 10.3390/pathogens13060450
- Subjects: PARASITOLOGIA; LEISHMANIOSE VISCERAL; LEISHMANIA INFANTUM; INFECÇÕES POR PROTOZOÁRIOS; CAQUEXIA; ANTIPARASITÁRIOS; LINFÓCITOS; LIPOPROTEÍNAS; GORDURAS; LIPÍDEOS
- Agências de fomento:
- Language: Inglês
- Imprenta:
- Source:
- Este periódico é de acesso aberto
- Este artigo é de acesso aberto
- URL de acesso aberto
- Cor do Acesso Aberto: gold
- Licença: cc-by
-
ABNT
SILVA, Renta Vieirade Sousa et al. Low plasma lipids are associated with relapsing and lethal Visceral Leishmaniasis in HIV-infected patients. Pathogens, v. 13, n. 6, p. 11 , 2024Tradução . . Disponível em: https://doi.org/10.3390/pathogens13060450. Acesso em: 03 jan. 2026. -
APA
Silva, R. V. S., Yasunaka, J. K. U. Y., Veloso, C. S., Sousa, E. A., Ferreira, M. M. L., Carvalho, V. S., et al. (2024). Low plasma lipids are associated with relapsing and lethal Visceral Leishmaniasis in HIV-infected patients. Pathogens, 13( 6), 11 . doi:10.3390/pathogens13060450 -
NLM
Silva RVS, Yasunaka JKUY, Veloso CS, Sousa EA, Ferreira MML, Carvalho VS, Ferreira GR, Costa DL, Costa CHN, Uliana SRB. Low plasma lipids are associated with relapsing and lethal Visceral Leishmaniasis in HIV-infected patients [Internet]. Pathogens. 2024 ; 13( 6): 11 .[citado 2026 jan. 03 ] Available from: https://doi.org/10.3390/pathogens13060450 -
Vancouver
Silva RVS, Yasunaka JKUY, Veloso CS, Sousa EA, Ferreira MML, Carvalho VS, Ferreira GR, Costa DL, Costa CHN, Uliana SRB. Low plasma lipids are associated with relapsing and lethal Visceral Leishmaniasis in HIV-infected patients [Internet]. Pathogens. 2024 ; 13( 6): 11 .[citado 2026 jan. 03 ] Available from: https://doi.org/10.3390/pathogens13060450 - Discovery of synthetic Leishmania Inhibitors by screening of a 2-arylbenzothiophene library
- Parasite burden in Leishmania (Leishmania) amazonensis-infected mice: validation of luciferase as a quantitative tool
- A dysflagellar mutant of Leishmania (Viannia) braziliensis isolated from a cutaneous leishmaniasis patient
- Combination therapy with Tamoxifen and Amphotericin B in experimental cutaneous Leishmaniasis
- The anticancer drug tamoxifen is active against Trypanosoma cruzi in vitro but ineffective in the treatment of the acute phase of Chagas disease in mice
- Susceptibility to miltefosine in brazilian clinical isolates of Leishmania (Viannia) braziliensis
- Antileishmanial activity of the estrogen receptor modulator raloxifene
- In vitro sensitivity of Leishmania (Viannia) braziliensis and Leishmania (Leishmania) amazonensis Brazilian isolates to meglumine antimoniate and amphotericin B
- Synthesis and in vitro activity of limonene derivatives against Leishmania and Trypanosoma
- Topical tamoxifen in the therapy of cutaneous leishmaniasis
Informações sobre o DOI: 10.3390/pathogens13060450 (Fonte: oaDOI API)
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
